NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 8,993,007
- Share change
- -2,709,235
- Total reported value
- $7,408,233
- Put/Call ratio
- 66%
- Price per share
- $0.82
- Number of holders
- 29
- Value change
- -$2,236,666
- Number of buys
- 9
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.3%
|
5,980,568
|
$5,083,483 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
3,543,384
|
$3,011,877 | — | 31 Dec 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.18%
|
475,862
|
$404,000 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.16%
|
430,800
|
$366,180 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
330,206
|
$280,675 | — | 31 Dec 2024 | |
| EDBI Pte Ltd |
13F
|
Company |
0.08%
|
222,136
|
$188,816 | — | 31 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.06%
|
162,580
|
$138,193 | — | 31 Dec 2024 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.05%
|
140,100
|
$119,085 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.04%
|
109,209
|
$92,828 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
103,054
|
$87,596 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
97,749
|
$83,087 | — | 31 Dec 2024 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.03%
|
74,723
|
$63,515 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,800
|
$54,230 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
58,358
|
$49,604 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
30,370
|
$25,815 | — | 31 Dec 2024 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
28,760
|
$24,446 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
22,037
|
$18,731 | — | 31 Dec 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0%
|
13,087
|
$11,000 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0%
|
10,685
|
$9,082 | — | 31 Dec 2024 | |
| Freestone Capital Holdings, LLC |
13F
|
Company |
0%
|
10,000
|
$8,500 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
1,367
|
$1,160 | — | 31 Dec 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,191
|
$1,012 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0%
|
931
|
$791 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
905
|
$769 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
566
|
$481 | — | 31 Dec 2024 | |
| Vermillion Wealth Management, Inc. |
13F
|
Company |
0%
|
200
|
$170 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
50
|
$43 | — | 31 Dec 2024 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2025
As of 31 Mar 2025,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,993,007 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., SG Americas Securities, LLC, Stonepine Capital Management, LLC, TWO SIGMA ADVISERS, LP, UBS Group AG, TWO SIGMA INVESTMENTS, LP, Aberdeen Group plc, BNP PARIBAS FINANCIAL MARKETS, Alberta Investment Management Corp, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
27
Q1 2025 holders
29
Holder diff
2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.